Format

Send to

Choose Destination
See comment in PubMed Commons below
Immunity. 2013 Jun 27;38(6):1092-104. doi: 10.1016/j.immuni.2013.06.009.

Immune effector mechanisms implicated in atherosclerosis: from mice to humans.

Author information

1
Brigham and Women's Hospital, Harvard Medical School, 77 Avenue Louis Pasteur, NRB7, Boston, MA 02115, USA. plibby@rics.bwh.harvard.edu

Erratum in

  • Immunity. 2013 Aug 22;39(2):413.

Abstract

According to the traditional view, atherosclerosis results from a passive buildup of cholesterol in the artery wall. Yet, burgeoning evidence implicates inflammation and immune effector mechanisms in the pathogenesis of this disease. Both innate and adaptive immunity operate during atherogenesis and link many traditional risk factors to altered arterial functions. Inflammatory pathways have become targets in the quest for novel preventive and therapeutic strategies against cardiovascular disease, a growing contributor to morbidity and mortality worldwide. Here we review current experimental and clinical knowledge of the pathogenesis of atherosclerosis through an immunological lens and how host defense mechanisms essential for survival of the species actually contribute to this chronic disease but also present new opportunities for its mitigation.

PMID:
23809160
PMCID:
PMC3764500
DOI:
10.1016/j.immuni.2013.06.009
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center